Global CAR-T Cell Therapy Market Growth 2026-2032
The global CAR-T Cell Therapy market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
United States market for CAR-T Cell Therapy is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for CAR-T Cell Therapy is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for CAR-T Cell Therapy is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key CAR-T Cell Therapy players cover Bristol Myers Squibb, Gilead Sciences, Novartis, Autolus, Janssen, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “CAR-T Cell Therapy Industry Forecast” looks at past sales and reviews total world CAR-T Cell Therapy sales in 2025, providing a comprehensive analysis by region and market sector of projected CAR-T Cell Therapy sales for 2026 through 2032. With CAR-T Cell Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world CAR-T Cell Therapy industry.
This Insight Report provides a comprehensive analysis of the global CAR-T Cell Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on CAR-T Cell Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global CAR-T Cell Therapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for CAR-T Cell Therapy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global CAR-T Cell Therapy.
This report presents a comprehensive overview, market shares, and growth opportunities of CAR-T Cell Therapy market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global CAR-T Cell Therapy market?
What factors are driving CAR-T Cell Therapy market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do CAR-T Cell Therapy market opportunities vary by end market size?
How does CAR-T Cell Therapy break out by Type, by Application?
United States market for CAR-T Cell Therapy is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for CAR-T Cell Therapy is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for CAR-T Cell Therapy is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key CAR-T Cell Therapy players cover Bristol Myers Squibb, Gilead Sciences, Novartis, Autolus, Janssen, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “CAR-T Cell Therapy Industry Forecast” looks at past sales and reviews total world CAR-T Cell Therapy sales in 2025, providing a comprehensive analysis by region and market sector of projected CAR-T Cell Therapy sales for 2026 through 2032. With CAR-T Cell Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world CAR-T Cell Therapy industry.
This Insight Report provides a comprehensive analysis of the global CAR-T Cell Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on CAR-T Cell Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global CAR-T Cell Therapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for CAR-T Cell Therapy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global CAR-T Cell Therapy.
This report presents a comprehensive overview, market shares, and growth opportunities of CAR-T Cell Therapy market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- CD19
- BCMA
- CD19/CD22
- Other
- Non-hodgkin Lymphoma
- Multiple Myeloma
- Acute Lymphoblastic Leukemia
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Bristol Myers Squibb
- Gilead Sciences
- Novartis
- Autolus
- Janssen
- JW Therapeutics
- Beijing Immunochina Medical Science & Technology
- Bioray Laboratories
What is the 10-year outlook for the global CAR-T Cell Therapy market?
What factors are driving CAR-T Cell Therapy market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do CAR-T Cell Therapy market opportunities vary by end market size?
How does CAR-T Cell Therapy break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global CAR-T Cell Therapy Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for CAR-T Cell Therapy by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for CAR-T Cell Therapy by Country/Region, 2021, 2025 & 2032
2.2 CAR-T Cell Therapy Segment by Type
2.2.1 CD19
2.2.2 BCMA
2.2.3 CD19/CD22
2.2.4 Other
2.2.5 CAR-T Cell Therapy Sales by Type
2.2.5.1 Global CAR-T Cell Therapy Sales Market Share by Type (2021-2026)
2.2.5.2 Global CAR-T Cell Therapy Revenue and Market Share by Type (2021-2026)
2.2.5.3 Global CAR-T Cell Therapy Sale Price by Type (2021-2026)
2.3 CAR-T Cell Therapy Segment by Application
2.3.1 Non-hodgkin Lymphoma
2.3.2 Multiple Myeloma
2.3.3 Acute Lymphoblastic Leukemia
2.3.4 Other
2.3.5 CAR-T Cell Therapy Sales by Application
2.3.5.1 Global CAR-T Cell Therapy Sale Market Share by Application (2021-2026)
2.3.5.2 Global CAR-T Cell Therapy Revenue and Market Share by Application (2021-2026)
2.3.5.3 Global CAR-T Cell Therapy Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global CAR-T Cell Therapy Breakdown Data by Company
3.1.1 Global CAR-T Cell Therapy Annual Sales by Company (2021-2026)
3.1.2 Global CAR-T Cell Therapy Sales Market Share by Company (2021-2026)
3.2 Global CAR-T Cell Therapy Annual Revenue by Company (2021-2026)
3.2.1 Global CAR-T Cell Therapy Revenue by Company (2021-2026)
3.2.2 Global CAR-T Cell Therapy Revenue Market Share by Company (2021-2026)
3.3 Global CAR-T Cell Therapy Sale Price by Company
3.4 Key Manufacturers CAR-T Cell Therapy Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers CAR-T Cell Therapy Product Location Distribution
3.4.2 Players CAR-T Cell Therapy Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR CAR-T CELL THERAPY BY GEOGRAPHIC REGION
4.1 World Historic CAR-T Cell Therapy Market Size by Geographic Region (2021-2026)
4.1.1 Global CAR-T Cell Therapy Annual Sales by Geographic Region (2021-2026)
4.1.2 Global CAR-T Cell Therapy Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic CAR-T Cell Therapy Market Size by Country/Region (2021-2026)
4.2.1 Global CAR-T Cell Therapy Annual Sales by Country/Region (2021-2026)
4.2.2 Global CAR-T Cell Therapy Annual Revenue by Country/Region (2021-2026)
4.3 Americas CAR-T Cell Therapy Sales Growth
4.4 APAC CAR-T Cell Therapy Sales Growth
4.5 Europe CAR-T Cell Therapy Sales Growth
4.6 Middle East & Africa CAR-T Cell Therapy Sales Growth
5 AMERICAS
5.1 Americas CAR-T Cell Therapy Sales by Country
5.1.1 Americas CAR-T Cell Therapy Sales by Country (2021-2026)
5.1.2 Americas CAR-T Cell Therapy Revenue by Country (2021-2026)
5.2 Americas CAR-T Cell Therapy Sales by Type (2021-2026)
5.3 Americas CAR-T Cell Therapy Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC CAR-T Cell Therapy Sales by Region
6.1.1 APAC CAR-T Cell Therapy Sales by Region (2021-2026)
6.1.2 APAC CAR-T Cell Therapy Revenue by Region (2021-2026)
6.2 APAC CAR-T Cell Therapy Sales by Type (2021-2026)
6.3 APAC CAR-T Cell Therapy Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe CAR-T Cell Therapy by Country
7.1.1 Europe CAR-T Cell Therapy Sales by Country (2021-2026)
7.1.2 Europe CAR-T Cell Therapy Revenue by Country (2021-2026)
7.2 Europe CAR-T Cell Therapy Sales by Type (2021-2026)
7.3 Europe CAR-T Cell Therapy Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa CAR-T Cell Therapy by Country
8.1.1 Middle East & Africa CAR-T Cell Therapy Sales by Country (2021-2026)
8.1.2 Middle East & Africa CAR-T Cell Therapy Revenue by Country (2021-2026)
8.2 Middle East & Africa CAR-T Cell Therapy Sales by Type (2021-2026)
8.3 Middle East & Africa CAR-T Cell Therapy Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of CAR-T Cell Therapy
10.3 Manufacturing Process Analysis of CAR-T Cell Therapy
10.4 Industry Chain Structure of CAR-T Cell Therapy
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 CAR-T Cell Therapy Distributors
11.3 CAR-T Cell Therapy Customer
12 WORLD FORECAST REVIEW FOR CAR-T CELL THERAPY BY GEOGRAPHIC REGION
12.1 Global CAR-T Cell Therapy Market Size Forecast by Region
12.1.1 Global CAR-T Cell Therapy Forecast by Region (2027-2032)
12.1.2 Global CAR-T Cell Therapy Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global CAR-T Cell Therapy Forecast by Type (2027-2032)
12.7 Global CAR-T Cell Therapy Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Bristol Myers Squibb
13.1.1 Bristol Myers Squibb Company Information
13.1.2 Bristol Myers Squibb CAR-T Cell Therapy Product Portfolios and Specifications
13.1.3 Bristol Myers Squibb CAR-T Cell Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Bristol Myers Squibb Main Business Overview
13.1.5 Bristol Myers Squibb Latest Developments
13.2 Gilead Sciences
13.2.1 Gilead Sciences Company Information
13.2.2 Gilead Sciences CAR-T Cell Therapy Product Portfolios and Specifications
13.2.3 Gilead Sciences CAR-T Cell Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Gilead Sciences Main Business Overview
13.2.5 Gilead Sciences Latest Developments
13.3 Novartis
13.3.1 Novartis Company Information
13.3.2 Novartis CAR-T Cell Therapy Product Portfolios and Specifications
13.3.3 Novartis CAR-T Cell Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Novartis Main Business Overview
13.3.5 Novartis Latest Developments
13.4 Autolus
13.4.1 Autolus Company Information
13.4.2 Autolus CAR-T Cell Therapy Product Portfolios and Specifications
13.4.3 Autolus CAR-T Cell Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Autolus Main Business Overview
13.4.5 Autolus Latest Developments
13.5 Janssen
13.5.1 Janssen Company Information
13.5.2 Janssen CAR-T Cell Therapy Product Portfolios and Specifications
13.5.3 Janssen CAR-T Cell Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Janssen Main Business Overview
13.5.5 Janssen Latest Developments
13.6 JW Therapeutics
13.6.1 JW Therapeutics Company Information
13.6.2 JW Therapeutics CAR-T Cell Therapy Product Portfolios and Specifications
13.6.3 JW Therapeutics CAR-T Cell Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 JW Therapeutics Main Business Overview
13.6.5 JW Therapeutics Latest Developments
13.7 Beijing Immunochina Medical Science & Technology
13.7.1 Beijing Immunochina Medical Science & Technology Company Information
13.7.2 Beijing Immunochina Medical Science & Technology CAR-T Cell Therapy Product Portfolios and Specifications
13.7.3 Beijing Immunochina Medical Science & Technology CAR-T Cell Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Beijing Immunochina Medical Science & Technology Main Business Overview
13.7.5 Beijing Immunochina Medical Science & Technology Latest Developments
13.8 Bioray Laboratories
13.8.1 Bioray Laboratories Company Information
13.8.2 Bioray Laboratories CAR-T Cell Therapy Product Portfolios and Specifications
13.8.3 Bioray Laboratories CAR-T Cell Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Bioray Laboratories Main Business Overview
13.8.5 Bioray Laboratories Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global CAR-T Cell Therapy Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for CAR-T Cell Therapy by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for CAR-T Cell Therapy by Country/Region, 2021, 2025 & 2032
2.2 CAR-T Cell Therapy Segment by Type
2.2.1 CD19
2.2.2 BCMA
2.2.3 CD19/CD22
2.2.4 Other
2.2.5 CAR-T Cell Therapy Sales by Type
2.2.5.1 Global CAR-T Cell Therapy Sales Market Share by Type (2021-2026)
2.2.5.2 Global CAR-T Cell Therapy Revenue and Market Share by Type (2021-2026)
2.2.5.3 Global CAR-T Cell Therapy Sale Price by Type (2021-2026)
2.3 CAR-T Cell Therapy Segment by Application
2.3.1 Non-hodgkin Lymphoma
2.3.2 Multiple Myeloma
2.3.3 Acute Lymphoblastic Leukemia
2.3.4 Other
2.3.5 CAR-T Cell Therapy Sales by Application
2.3.5.1 Global CAR-T Cell Therapy Sale Market Share by Application (2021-2026)
2.3.5.2 Global CAR-T Cell Therapy Revenue and Market Share by Application (2021-2026)
2.3.5.3 Global CAR-T Cell Therapy Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global CAR-T Cell Therapy Breakdown Data by Company
3.1.1 Global CAR-T Cell Therapy Annual Sales by Company (2021-2026)
3.1.2 Global CAR-T Cell Therapy Sales Market Share by Company (2021-2026)
3.2 Global CAR-T Cell Therapy Annual Revenue by Company (2021-2026)
3.2.1 Global CAR-T Cell Therapy Revenue by Company (2021-2026)
3.2.2 Global CAR-T Cell Therapy Revenue Market Share by Company (2021-2026)
3.3 Global CAR-T Cell Therapy Sale Price by Company
3.4 Key Manufacturers CAR-T Cell Therapy Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers CAR-T Cell Therapy Product Location Distribution
3.4.2 Players CAR-T Cell Therapy Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR CAR-T CELL THERAPY BY GEOGRAPHIC REGION
4.1 World Historic CAR-T Cell Therapy Market Size by Geographic Region (2021-2026)
4.1.1 Global CAR-T Cell Therapy Annual Sales by Geographic Region (2021-2026)
4.1.2 Global CAR-T Cell Therapy Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic CAR-T Cell Therapy Market Size by Country/Region (2021-2026)
4.2.1 Global CAR-T Cell Therapy Annual Sales by Country/Region (2021-2026)
4.2.2 Global CAR-T Cell Therapy Annual Revenue by Country/Region (2021-2026)
4.3 Americas CAR-T Cell Therapy Sales Growth
4.4 APAC CAR-T Cell Therapy Sales Growth
4.5 Europe CAR-T Cell Therapy Sales Growth
4.6 Middle East & Africa CAR-T Cell Therapy Sales Growth
5 AMERICAS
5.1 Americas CAR-T Cell Therapy Sales by Country
5.1.1 Americas CAR-T Cell Therapy Sales by Country (2021-2026)
5.1.2 Americas CAR-T Cell Therapy Revenue by Country (2021-2026)
5.2 Americas CAR-T Cell Therapy Sales by Type (2021-2026)
5.3 Americas CAR-T Cell Therapy Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC CAR-T Cell Therapy Sales by Region
6.1.1 APAC CAR-T Cell Therapy Sales by Region (2021-2026)
6.1.2 APAC CAR-T Cell Therapy Revenue by Region (2021-2026)
6.2 APAC CAR-T Cell Therapy Sales by Type (2021-2026)
6.3 APAC CAR-T Cell Therapy Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe CAR-T Cell Therapy by Country
7.1.1 Europe CAR-T Cell Therapy Sales by Country (2021-2026)
7.1.2 Europe CAR-T Cell Therapy Revenue by Country (2021-2026)
7.2 Europe CAR-T Cell Therapy Sales by Type (2021-2026)
7.3 Europe CAR-T Cell Therapy Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa CAR-T Cell Therapy by Country
8.1.1 Middle East & Africa CAR-T Cell Therapy Sales by Country (2021-2026)
8.1.2 Middle East & Africa CAR-T Cell Therapy Revenue by Country (2021-2026)
8.2 Middle East & Africa CAR-T Cell Therapy Sales by Type (2021-2026)
8.3 Middle East & Africa CAR-T Cell Therapy Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of CAR-T Cell Therapy
10.3 Manufacturing Process Analysis of CAR-T Cell Therapy
10.4 Industry Chain Structure of CAR-T Cell Therapy
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 CAR-T Cell Therapy Distributors
11.3 CAR-T Cell Therapy Customer
12 WORLD FORECAST REVIEW FOR CAR-T CELL THERAPY BY GEOGRAPHIC REGION
12.1 Global CAR-T Cell Therapy Market Size Forecast by Region
12.1.1 Global CAR-T Cell Therapy Forecast by Region (2027-2032)
12.1.2 Global CAR-T Cell Therapy Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global CAR-T Cell Therapy Forecast by Type (2027-2032)
12.7 Global CAR-T Cell Therapy Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Bristol Myers Squibb
13.1.1 Bristol Myers Squibb Company Information
13.1.2 Bristol Myers Squibb CAR-T Cell Therapy Product Portfolios and Specifications
13.1.3 Bristol Myers Squibb CAR-T Cell Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Bristol Myers Squibb Main Business Overview
13.1.5 Bristol Myers Squibb Latest Developments
13.2 Gilead Sciences
13.2.1 Gilead Sciences Company Information
13.2.2 Gilead Sciences CAR-T Cell Therapy Product Portfolios and Specifications
13.2.3 Gilead Sciences CAR-T Cell Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Gilead Sciences Main Business Overview
13.2.5 Gilead Sciences Latest Developments
13.3 Novartis
13.3.1 Novartis Company Information
13.3.2 Novartis CAR-T Cell Therapy Product Portfolios and Specifications
13.3.3 Novartis CAR-T Cell Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Novartis Main Business Overview
13.3.5 Novartis Latest Developments
13.4 Autolus
13.4.1 Autolus Company Information
13.4.2 Autolus CAR-T Cell Therapy Product Portfolios and Specifications
13.4.3 Autolus CAR-T Cell Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Autolus Main Business Overview
13.4.5 Autolus Latest Developments
13.5 Janssen
13.5.1 Janssen Company Information
13.5.2 Janssen CAR-T Cell Therapy Product Portfolios and Specifications
13.5.3 Janssen CAR-T Cell Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Janssen Main Business Overview
13.5.5 Janssen Latest Developments
13.6 JW Therapeutics
13.6.1 JW Therapeutics Company Information
13.6.2 JW Therapeutics CAR-T Cell Therapy Product Portfolios and Specifications
13.6.3 JW Therapeutics CAR-T Cell Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 JW Therapeutics Main Business Overview
13.6.5 JW Therapeutics Latest Developments
13.7 Beijing Immunochina Medical Science & Technology
13.7.1 Beijing Immunochina Medical Science & Technology Company Information
13.7.2 Beijing Immunochina Medical Science & Technology CAR-T Cell Therapy Product Portfolios and Specifications
13.7.3 Beijing Immunochina Medical Science & Technology CAR-T Cell Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Beijing Immunochina Medical Science & Technology Main Business Overview
13.7.5 Beijing Immunochina Medical Science & Technology Latest Developments
13.8 Bioray Laboratories
13.8.1 Bioray Laboratories Company Information
13.8.2 Bioray Laboratories CAR-T Cell Therapy Product Portfolios and Specifications
13.8.3 Bioray Laboratories CAR-T Cell Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Bioray Laboratories Main Business Overview
13.8.5 Bioray Laboratories Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. CAR-T Cell Therapy Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. CAR-T Cell Therapy Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of CD19
Table 4. Major Players of BCMA
Table 5. Major Players of CD19/CD22
Table 6. Major Players of Other
Table 7. Global CAR-T Cell Therapy Sales by Type (2021-2026) & (K Units)
Table 8. Global CAR-T Cell Therapy Sales Market Share by Type (2021-2026)
Table 9. Global CAR-T Cell Therapy Revenue by Type (2021-2026) & ($ million)
Table 10. Global CAR-T Cell Therapy Revenue Market Share by Type (2021-2026)
Table 11. Global CAR-T Cell Therapy Sale Price by Type (2021-2026) & (US$/Unit)
Table 12. Global CAR-T Cell Therapy Sale by Application (2021-2026) & (K Units)
Table 13. Global CAR-T Cell Therapy Sale Market Share by Application (2021-2026)
Table 14. Global CAR-T Cell Therapy Revenue by Application (2021-2026) & ($ million)
Table 15. Global CAR-T Cell Therapy Revenue Market Share by Application (2021-2026)
Table 16. Global CAR-T Cell Therapy Sale Price by Application (2021-2026) & (US$/Unit)
Table 17. Global CAR-T Cell Therapy Sales by Company (2021-2026) & (K Units)
Table 18. Global CAR-T Cell Therapy Sales Market Share by Company (2021-2026)
Table 19. Global CAR-T Cell Therapy Revenue by Company (2021-2026) & ($ millions)
Table 20. Global CAR-T Cell Therapy Revenue Market Share by Company (2021-2026)
Table 21. Global CAR-T Cell Therapy Sale Price by Company (2021-2026) & (US$/Unit)
Table 22. Key Manufacturers CAR-T Cell Therapy Producing Area Distribution and Sales Area
Table 23. Players CAR-T Cell Therapy Products Offered
Table 24. CAR-T Cell Therapy Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global CAR-T Cell Therapy Sales by Geographic Region (2021-2026) & (K Units)
Table 28. Global CAR-T Cell Therapy Sales Market Share Geographic Region (2021-2026)
Table 29. Global CAR-T Cell Therapy Revenue by Geographic Region (2021-2026) & ($ millions)
Table 30. Global CAR-T Cell Therapy Revenue Market Share by Geographic Region (2021-2026)
Table 31. Global CAR-T Cell Therapy Sales by Country/Region (2021-2026) & (K Units)
Table 32. Global CAR-T Cell Therapy Sales Market Share by Country/Region (2021-2026)
Table 33. Global CAR-T Cell Therapy Revenue by Country/Region (2021-2026) & ($ millions)
Table 34. Global CAR-T Cell Therapy Revenue Market Share by Country/Region (2021-2026)
Table 35. Americas CAR-T Cell Therapy Sales by Country (2021-2026) & (K Units)
Table 36. Americas CAR-T Cell Therapy Sales Market Share by Country (2021-2026)
Table 37. Americas CAR-T Cell Therapy Revenue by Country (2021-2026) & ($ millions)
Table 38. Americas CAR-T Cell Therapy Sales by Type (2021-2026) & (K Units)
Table 39. Americas CAR-T Cell Therapy Sales by Application (2021-2026) & (K Units)
Table 40. APAC CAR-T Cell Therapy Sales by Region (2021-2026) & (K Units)
Table 41. APAC CAR-T Cell Therapy Sales Market Share by Region (2021-2026)
Table 42. APAC CAR-T Cell Therapy Revenue by Region (2021-2026) & ($ millions)
Table 43. APAC CAR-T Cell Therapy Sales by Type (2021-2026) & (K Units)
Table 44. APAC CAR-T Cell Therapy Sales by Application (2021-2026) & (K Units)
Table 45. Europe CAR-T Cell Therapy Sales by Country (2021-2026) & (K Units)
Table 46. Europe CAR-T Cell Therapy Revenue by Country (2021-2026) & ($ millions)
Table 47. Europe CAR-T Cell Therapy Sales by Type (2021-2026) & (K Units)
Table 48. Europe CAR-T Cell Therapy Sales by Application (2021-2026) & (K Units)
Table 49. Middle East & Africa CAR-T Cell Therapy Sales by Country (2021-2026) & (K Units)
Table 50. Middle East & Africa CAR-T Cell Therapy Revenue Market Share by Country (2021-2026)
Table 51. Middle East & Africa CAR-T Cell Therapy Sales by Type (2021-2026) & (K Units)
Table 52. Middle East & Africa CAR-T Cell Therapy Sales by Application (2021-2026) & (K Units)
Table 53. Key Market Drivers & Growth Opportunities of CAR-T Cell Therapy
Table 54. Key Market Challenges & Risks of CAR-T Cell Therapy
Table 55. Key Industry Trends of CAR-T Cell Therapy
Table 56. CAR-T Cell Therapy Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. CAR-T Cell Therapy Distributors List
Table 59. CAR-T Cell Therapy Customer List
Table 60. Global CAR-T Cell Therapy Sales Forecast by Region (2027-2032) & (K Units)
Table 61. Global CAR-T Cell Therapy Revenue Forecast by Region (2027-2032) & ($ millions)
Table 62. Americas CAR-T Cell Therapy Sales Forecast by Country (2027-2032) & (K Units)
Table 63. Americas CAR-T Cell Therapy Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 64. APAC CAR-T Cell Therapy Sales Forecast by Region (2027-2032) & (K Units)
Table 65. APAC CAR-T Cell Therapy Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 66. Europe CAR-T Cell Therapy Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Europe CAR-T Cell Therapy Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Middle East & Africa CAR-T Cell Therapy Sales Forecast by Country (2027-2032) & (K Units)
Table 69. Middle East & Africa CAR-T Cell Therapy Revenue Forecast by Country (2027-2032) & ($ millions)
Table 70. Global CAR-T Cell Therapy Sales Forecast by Type (2027-2032) & (K Units)
Table 71. Global CAR-T Cell Therapy Revenue Forecast by Type (2027-2032) & ($ millions)
Table 72. Global CAR-T Cell Therapy Sales Forecast by Application (2027-2032) & (K Units)
Table 73. Global CAR-T Cell Therapy Revenue Forecast by Application (2027-2032) & ($ millions)
Table 74. Bristol Myers Squibb Basic Information, CAR-T Cell Therapy Manufacturing Base, Sales Area and Its Competitors
Table 75. Bristol Myers Squibb CAR-T Cell Therapy Product Portfolios and Specifications
Table 76. Bristol Myers Squibb CAR-T Cell Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 77. Bristol Myers Squibb Main Business
Table 78. Bristol Myers Squibb Latest Developments
Table 79. Gilead Sciences Basic Information, CAR-T Cell Therapy Manufacturing Base, Sales Area and Its Competitors
Table 80. Gilead Sciences CAR-T Cell Therapy Product Portfolios and Specifications
Table 81. Gilead Sciences CAR-T Cell Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 82. Gilead Sciences Main Business
Table 83. Gilead Sciences Latest Developments
Table 84. Novartis Basic Information, CAR-T Cell Therapy Manufacturing Base, Sales Area and Its Competitors
Table 85. Novartis CAR-T Cell Therapy Product Portfolios and Specifications
Table 86. Novartis CAR-T Cell Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 87. Novartis Main Business
Table 88. Novartis Latest Developments
Table 89. Autolus Basic Information, CAR-T Cell Therapy Manufacturing Base, Sales Area and Its Competitors
Table 90. Autolus CAR-T Cell Therapy Product Portfolios and Specifications
Table 91. Autolus CAR-T Cell Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 92. Autolus Main Business
Table 93. Autolus Latest Developments
Table 94. Janssen Basic Information, CAR-T Cell Therapy Manufacturing Base, Sales Area and Its Competitors
Table 95. Janssen CAR-T Cell Therapy Product Portfolios and Specifications
Table 96. Janssen CAR-T Cell Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 97. Janssen Main Business
Table 98. Janssen Latest Developments
Table 99. JW Therapeutics Basic Information, CAR-T Cell Therapy Manufacturing Base, Sales Area and Its Competitors
Table 100. JW Therapeutics CAR-T Cell Therapy Product Portfolios and Specifications
Table 101. JW Therapeutics CAR-T Cell Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 102. JW Therapeutics Main Business
Table 103. JW Therapeutics Latest Developments
Table 104. Beijing Immunochina Medical Science & Technology Basic Information, CAR-T Cell Therapy Manufacturing Base, Sales Area and Its Competitors
Table 105. Beijing Immunochina Medical Science & Technology CAR-T Cell Therapy Product Portfolios and Specifications
Table 106. Beijing Immunochina Medical Science & Technology CAR-T Cell Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 107. Beijing Immunochina Medical Science & Technology Main Business
Table 108. Beijing Immunochina Medical Science & Technology Latest Developments
Table 109. Bioray Laboratories Basic Information, CAR-T Cell Therapy Manufacturing Base, Sales Area and Its Competitors
Table 110. Bioray Laboratories CAR-T Cell Therapy Product Portfolios and Specifications
Table 111. Bioray Laboratories CAR-T Cell Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 112. Bioray Laboratories Main Business
Table 113. Bioray Laboratories Latest Developments
Table 1. CAR-T Cell Therapy Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. CAR-T Cell Therapy Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of CD19
Table 4. Major Players of BCMA
Table 5. Major Players of CD19/CD22
Table 6. Major Players of Other
Table 7. Global CAR-T Cell Therapy Sales by Type (2021-2026) & (K Units)
Table 8. Global CAR-T Cell Therapy Sales Market Share by Type (2021-2026)
Table 9. Global CAR-T Cell Therapy Revenue by Type (2021-2026) & ($ million)
Table 10. Global CAR-T Cell Therapy Revenue Market Share by Type (2021-2026)
Table 11. Global CAR-T Cell Therapy Sale Price by Type (2021-2026) & (US$/Unit)
Table 12. Global CAR-T Cell Therapy Sale by Application (2021-2026) & (K Units)
Table 13. Global CAR-T Cell Therapy Sale Market Share by Application (2021-2026)
Table 14. Global CAR-T Cell Therapy Revenue by Application (2021-2026) & ($ million)
Table 15. Global CAR-T Cell Therapy Revenue Market Share by Application (2021-2026)
Table 16. Global CAR-T Cell Therapy Sale Price by Application (2021-2026) & (US$/Unit)
Table 17. Global CAR-T Cell Therapy Sales by Company (2021-2026) & (K Units)
Table 18. Global CAR-T Cell Therapy Sales Market Share by Company (2021-2026)
Table 19. Global CAR-T Cell Therapy Revenue by Company (2021-2026) & ($ millions)
Table 20. Global CAR-T Cell Therapy Revenue Market Share by Company (2021-2026)
Table 21. Global CAR-T Cell Therapy Sale Price by Company (2021-2026) & (US$/Unit)
Table 22. Key Manufacturers CAR-T Cell Therapy Producing Area Distribution and Sales Area
Table 23. Players CAR-T Cell Therapy Products Offered
Table 24. CAR-T Cell Therapy Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global CAR-T Cell Therapy Sales by Geographic Region (2021-2026) & (K Units)
Table 28. Global CAR-T Cell Therapy Sales Market Share Geographic Region (2021-2026)
Table 29. Global CAR-T Cell Therapy Revenue by Geographic Region (2021-2026) & ($ millions)
Table 30. Global CAR-T Cell Therapy Revenue Market Share by Geographic Region (2021-2026)
Table 31. Global CAR-T Cell Therapy Sales by Country/Region (2021-2026) & (K Units)
Table 32. Global CAR-T Cell Therapy Sales Market Share by Country/Region (2021-2026)
Table 33. Global CAR-T Cell Therapy Revenue by Country/Region (2021-2026) & ($ millions)
Table 34. Global CAR-T Cell Therapy Revenue Market Share by Country/Region (2021-2026)
Table 35. Americas CAR-T Cell Therapy Sales by Country (2021-2026) & (K Units)
Table 36. Americas CAR-T Cell Therapy Sales Market Share by Country (2021-2026)
Table 37. Americas CAR-T Cell Therapy Revenue by Country (2021-2026) & ($ millions)
Table 38. Americas CAR-T Cell Therapy Sales by Type (2021-2026) & (K Units)
Table 39. Americas CAR-T Cell Therapy Sales by Application (2021-2026) & (K Units)
Table 40. APAC CAR-T Cell Therapy Sales by Region (2021-2026) & (K Units)
Table 41. APAC CAR-T Cell Therapy Sales Market Share by Region (2021-2026)
Table 42. APAC CAR-T Cell Therapy Revenue by Region (2021-2026) & ($ millions)
Table 43. APAC CAR-T Cell Therapy Sales by Type (2021-2026) & (K Units)
Table 44. APAC CAR-T Cell Therapy Sales by Application (2021-2026) & (K Units)
Table 45. Europe CAR-T Cell Therapy Sales by Country (2021-2026) & (K Units)
Table 46. Europe CAR-T Cell Therapy Revenue by Country (2021-2026) & ($ millions)
Table 47. Europe CAR-T Cell Therapy Sales by Type (2021-2026) & (K Units)
Table 48. Europe CAR-T Cell Therapy Sales by Application (2021-2026) & (K Units)
Table 49. Middle East & Africa CAR-T Cell Therapy Sales by Country (2021-2026) & (K Units)
Table 50. Middle East & Africa CAR-T Cell Therapy Revenue Market Share by Country (2021-2026)
Table 51. Middle East & Africa CAR-T Cell Therapy Sales by Type (2021-2026) & (K Units)
Table 52. Middle East & Africa CAR-T Cell Therapy Sales by Application (2021-2026) & (K Units)
Table 53. Key Market Drivers & Growth Opportunities of CAR-T Cell Therapy
Table 54. Key Market Challenges & Risks of CAR-T Cell Therapy
Table 55. Key Industry Trends of CAR-T Cell Therapy
Table 56. CAR-T Cell Therapy Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. CAR-T Cell Therapy Distributors List
Table 59. CAR-T Cell Therapy Customer List
Table 60. Global CAR-T Cell Therapy Sales Forecast by Region (2027-2032) & (K Units)
Table 61. Global CAR-T Cell Therapy Revenue Forecast by Region (2027-2032) & ($ millions)
Table 62. Americas CAR-T Cell Therapy Sales Forecast by Country (2027-2032) & (K Units)
Table 63. Americas CAR-T Cell Therapy Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 64. APAC CAR-T Cell Therapy Sales Forecast by Region (2027-2032) & (K Units)
Table 65. APAC CAR-T Cell Therapy Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 66. Europe CAR-T Cell Therapy Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Europe CAR-T Cell Therapy Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Middle East & Africa CAR-T Cell Therapy Sales Forecast by Country (2027-2032) & (K Units)
Table 69. Middle East & Africa CAR-T Cell Therapy Revenue Forecast by Country (2027-2032) & ($ millions)
Table 70. Global CAR-T Cell Therapy Sales Forecast by Type (2027-2032) & (K Units)
Table 71. Global CAR-T Cell Therapy Revenue Forecast by Type (2027-2032) & ($ millions)
Table 72. Global CAR-T Cell Therapy Sales Forecast by Application (2027-2032) & (K Units)
Table 73. Global CAR-T Cell Therapy Revenue Forecast by Application (2027-2032) & ($ millions)
Table 74. Bristol Myers Squibb Basic Information, CAR-T Cell Therapy Manufacturing Base, Sales Area and Its Competitors
Table 75. Bristol Myers Squibb CAR-T Cell Therapy Product Portfolios and Specifications
Table 76. Bristol Myers Squibb CAR-T Cell Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 77. Bristol Myers Squibb Main Business
Table 78. Bristol Myers Squibb Latest Developments
Table 79. Gilead Sciences Basic Information, CAR-T Cell Therapy Manufacturing Base, Sales Area and Its Competitors
Table 80. Gilead Sciences CAR-T Cell Therapy Product Portfolios and Specifications
Table 81. Gilead Sciences CAR-T Cell Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 82. Gilead Sciences Main Business
Table 83. Gilead Sciences Latest Developments
Table 84. Novartis Basic Information, CAR-T Cell Therapy Manufacturing Base, Sales Area and Its Competitors
Table 85. Novartis CAR-T Cell Therapy Product Portfolios and Specifications
Table 86. Novartis CAR-T Cell Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 87. Novartis Main Business
Table 88. Novartis Latest Developments
Table 89. Autolus Basic Information, CAR-T Cell Therapy Manufacturing Base, Sales Area and Its Competitors
Table 90. Autolus CAR-T Cell Therapy Product Portfolios and Specifications
Table 91. Autolus CAR-T Cell Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 92. Autolus Main Business
Table 93. Autolus Latest Developments
Table 94. Janssen Basic Information, CAR-T Cell Therapy Manufacturing Base, Sales Area and Its Competitors
Table 95. Janssen CAR-T Cell Therapy Product Portfolios and Specifications
Table 96. Janssen CAR-T Cell Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 97. Janssen Main Business
Table 98. Janssen Latest Developments
Table 99. JW Therapeutics Basic Information, CAR-T Cell Therapy Manufacturing Base, Sales Area and Its Competitors
Table 100. JW Therapeutics CAR-T Cell Therapy Product Portfolios and Specifications
Table 101. JW Therapeutics CAR-T Cell Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 102. JW Therapeutics Main Business
Table 103. JW Therapeutics Latest Developments
Table 104. Beijing Immunochina Medical Science & Technology Basic Information, CAR-T Cell Therapy Manufacturing Base, Sales Area and Its Competitors
Table 105. Beijing Immunochina Medical Science & Technology CAR-T Cell Therapy Product Portfolios and Specifications
Table 106. Beijing Immunochina Medical Science & Technology CAR-T Cell Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 107. Beijing Immunochina Medical Science & Technology Main Business
Table 108. Beijing Immunochina Medical Science & Technology Latest Developments
Table 109. Bioray Laboratories Basic Information, CAR-T Cell Therapy Manufacturing Base, Sales Area and Its Competitors
Table 110. Bioray Laboratories CAR-T Cell Therapy Product Portfolios and Specifications
Table 111. Bioray Laboratories CAR-T Cell Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 112. Bioray Laboratories Main Business
Table 113. Bioray Laboratories Latest Developments
LIST OF FIGURES
Figure 1. Picture of CAR-T Cell Therapy
Figure 2. CAR-T Cell Therapy Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global CAR-T Cell Therapy Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global CAR-T Cell Therapy Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. CAR-T Cell Therapy Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. CAR-T Cell Therapy Sales Market Share by Country/Region (2025)
Figure 10. CAR-T Cell Therapy Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of CD19
Figure 12. Product Picture of BCMA
Figure 13. Product Picture of CD19/CD22
Figure 14. Product Picture of Other
Figure 15. Global CAR-T Cell Therapy Sales Market Share by Type in 2026
Figure 16. Global CAR-T Cell Therapy Revenue Market Share by Type (2021-2026)
Figure 17. CAR-T Cell Therapy Consumed in Non-hodgkin Lymphoma
Figure 18. Global CAR-T Cell Therapy Market: Non-hodgkin Lymphoma (2021-2026) & (K Units)
Figure 19. CAR-T Cell Therapy Consumed in Multiple Myeloma
Figure 20. Global CAR-T Cell Therapy Market: Multiple Myeloma (2021-2026) & (K Units)
Figure 21. CAR-T Cell Therapy Consumed in Acute Lymphoblastic Leukemia
Figure 22. Global CAR-T Cell Therapy Market: Acute Lymphoblastic Leukemia (2021-2026) & (K Units)
Figure 23. CAR-T Cell Therapy Consumed in Other
Figure 24. Global CAR-T Cell Therapy Market: Other (2021-2026) & (K Units)
Figure 25. Global CAR-T Cell Therapy Sale Market Share by Application (2025)
Figure 26. Global CAR-T Cell Therapy Revenue Market Share by Application in 2026
Figure 27. CAR-T Cell Therapy Sales by Company in 2026 (K Units)
Figure 28. Global CAR-T Cell Therapy Sales Market Share by Company in 2026
Figure 29. CAR-T Cell Therapy Revenue by Company in 2026 ($ millions)
Figure 30. Global CAR-T Cell Therapy Revenue Market Share by Company in 2026
Figure 31. Global CAR-T Cell Therapy Sales Market Share by Geographic Region (2021-2026)
Figure 32. Global CAR-T Cell Therapy Revenue Market Share by Geographic Region in 2026
Figure 33. Americas CAR-T Cell Therapy Sales 2021-2026 (K Units)
Figure 34. Americas CAR-T Cell Therapy Revenue 2021-2026 ($ millions)
Figure 35. APAC CAR-T Cell Therapy Sales 2021-2026 (K Units)
Figure 36. APAC CAR-T Cell Therapy Revenue 2021-2026 ($ millions)
Figure 37. Europe CAR-T Cell Therapy Sales 2021-2026 (K Units)
Figure 38. Europe CAR-T Cell Therapy Revenue 2021-2026 ($ millions)
Figure 39. Middle East & Africa CAR-T Cell Therapy Sales 2021-2026 (K Units)
Figure 40. Middle East & Africa CAR-T Cell Therapy Revenue 2021-2026 ($ millions)
Figure 41. Americas CAR-T Cell Therapy Sales Market Share by Country in 2026
Figure 42. Americas CAR-T Cell Therapy Revenue Market Share by Country (2021-2026)
Figure 43. Americas CAR-T Cell Therapy Sales Market Share by Type (2021-2026)
Figure 44. Americas CAR-T Cell Therapy Sales Market Share by Application (2021-2026)
Figure 45. United States CAR-T Cell Therapy Revenue Growth 2021-2026 ($ millions)
Figure 46. Canada CAR-T Cell Therapy Revenue Growth 2021-2026 ($ millions)
Figure 47. Mexico CAR-T Cell Therapy Revenue Growth 2021-2026 ($ millions)
Figure 48. Brazil CAR-T Cell Therapy Revenue Growth 2021-2026 ($ millions)
Figure 49. APAC CAR-T Cell Therapy Sales Market Share by Region in 2026
Figure 50. APAC CAR-T Cell Therapy Revenue Market Share by Region (2021-2026)
Figure 51. APAC CAR-T Cell Therapy Sales Market Share by Type (2021-2026)
Figure 52. APAC CAR-T Cell Therapy Sales Market Share by Application (2021-2026)
Figure 53. China CAR-T Cell Therapy Revenue Growth 2021-2026 ($ millions)
Figure 54. Japan CAR-T Cell Therapy Revenue Growth 2021-2026 ($ millions)
Figure 55. South Korea CAR-T Cell Therapy Revenue Growth 2021-2026 ($ millions)
Figure 56. Southeast Asia CAR-T Cell Therapy Revenue Growth 2021-2026 ($ millions)
Figure 57. India CAR-T Cell Therapy Revenue Growth 2021-2026 ($ millions)
Figure 58. Australia CAR-T Cell Therapy Revenue Growth 2021-2026 ($ millions)
Figure 59. China Taiwan CAR-T Cell Therapy Revenue Growth 2021-2026 ($ millions)
Figure 60. Europe CAR-T Cell Therapy Sales Market Share by Country in 2026
Figure 61. Europe CAR-T Cell Therapy Revenue Market Share by Country (2021-2026)
Figure 62. Europe CAR-T Cell Therapy Sales Market Share by Type (2021-2026)
Figure 63. Europe CAR-T Cell Therapy Sales Market Share by Application (2021-2026)
Figure 64. Germany CAR-T Cell Therapy Revenue Growth 2021-2026 ($ millions)
Figure 65. France CAR-T Cell Therapy Revenue Growth 2021-2026 ($ millions)
Figure 66. UK CAR-T Cell Therapy Revenue Growth 2021-2026 ($ millions)
Figure 67. Italy CAR-T Cell Therapy Revenue Growth 2021-2026 ($ millions)
Figure 68. Russia CAR-T Cell Therapy Revenue Growth 2021-2026 ($ millions)
Figure 69. Middle East & Africa CAR-T Cell Therapy Sales Market Share by Country (2021-2026)
Figure 70. Middle East & Africa CAR-T Cell Therapy Sales Market Share by Type (2021-2026)
Figure 71. Middle East & Africa CAR-T Cell Therapy Sales Market Share by Application (2021-2026)
Figure 72. Egypt CAR-T Cell Therapy Revenue Growth 2021-2026 ($ millions)
Figure 73. South Africa CAR-T Cell Therapy Revenue Growth 2021-2026 ($ millions)
Figure 74. Israel CAR-T Cell Therapy Revenue Growth 2021-2026 ($ millions)
Figure 75. Turkey CAR-T Cell Therapy Revenue Growth 2021-2026 ($ millions)
Figure 76. GCC Countries CAR-T Cell Therapy Revenue Growth 2021-2026 ($ millions)
Figure 77. Manufacturing Cost Structure Analysis of CAR-T Cell Therapy in 2026
Figure 78. Manufacturing Process Analysis of CAR-T Cell Therapy
Figure 79. Industry Chain Structure of CAR-T Cell Therapy
Figure 80. Channels of Distribution
Figure 81. Global CAR-T Cell Therapy Sales Market Forecast by Region (2027-2032)
Figure 82. Global CAR-T Cell Therapy Revenue Market Share Forecast by Region (2027-2032)
Figure 83. Global CAR-T Cell Therapy Sales Market Share Forecast by Type (2027-2032)
Figure 84. Global CAR-T Cell Therapy Revenue Market Share Forecast by Type (2027-2032)
Figure 85. Global CAR-T Cell Therapy Sales Market Share Forecast by Application (2027-2032)
Figure 86. Global CAR-T Cell Therapy Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of CAR-T Cell Therapy
Figure 2. CAR-T Cell Therapy Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global CAR-T Cell Therapy Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global CAR-T Cell Therapy Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. CAR-T Cell Therapy Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. CAR-T Cell Therapy Sales Market Share by Country/Region (2025)
Figure 10. CAR-T Cell Therapy Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of CD19
Figure 12. Product Picture of BCMA
Figure 13. Product Picture of CD19/CD22
Figure 14. Product Picture of Other
Figure 15. Global CAR-T Cell Therapy Sales Market Share by Type in 2026
Figure 16. Global CAR-T Cell Therapy Revenue Market Share by Type (2021-2026)
Figure 17. CAR-T Cell Therapy Consumed in Non-hodgkin Lymphoma
Figure 18. Global CAR-T Cell Therapy Market: Non-hodgkin Lymphoma (2021-2026) & (K Units)
Figure 19. CAR-T Cell Therapy Consumed in Multiple Myeloma
Figure 20. Global CAR-T Cell Therapy Market: Multiple Myeloma (2021-2026) & (K Units)
Figure 21. CAR-T Cell Therapy Consumed in Acute Lymphoblastic Leukemia
Figure 22. Global CAR-T Cell Therapy Market: Acute Lymphoblastic Leukemia (2021-2026) & (K Units)
Figure 23. CAR-T Cell Therapy Consumed in Other
Figure 24. Global CAR-T Cell Therapy Market: Other (2021-2026) & (K Units)
Figure 25. Global CAR-T Cell Therapy Sale Market Share by Application (2025)
Figure 26. Global CAR-T Cell Therapy Revenue Market Share by Application in 2026
Figure 27. CAR-T Cell Therapy Sales by Company in 2026 (K Units)
Figure 28. Global CAR-T Cell Therapy Sales Market Share by Company in 2026
Figure 29. CAR-T Cell Therapy Revenue by Company in 2026 ($ millions)
Figure 30. Global CAR-T Cell Therapy Revenue Market Share by Company in 2026
Figure 31. Global CAR-T Cell Therapy Sales Market Share by Geographic Region (2021-2026)
Figure 32. Global CAR-T Cell Therapy Revenue Market Share by Geographic Region in 2026
Figure 33. Americas CAR-T Cell Therapy Sales 2021-2026 (K Units)
Figure 34. Americas CAR-T Cell Therapy Revenue 2021-2026 ($ millions)
Figure 35. APAC CAR-T Cell Therapy Sales 2021-2026 (K Units)
Figure 36. APAC CAR-T Cell Therapy Revenue 2021-2026 ($ millions)
Figure 37. Europe CAR-T Cell Therapy Sales 2021-2026 (K Units)
Figure 38. Europe CAR-T Cell Therapy Revenue 2021-2026 ($ millions)
Figure 39. Middle East & Africa CAR-T Cell Therapy Sales 2021-2026 (K Units)
Figure 40. Middle East & Africa CAR-T Cell Therapy Revenue 2021-2026 ($ millions)
Figure 41. Americas CAR-T Cell Therapy Sales Market Share by Country in 2026
Figure 42. Americas CAR-T Cell Therapy Revenue Market Share by Country (2021-2026)
Figure 43. Americas CAR-T Cell Therapy Sales Market Share by Type (2021-2026)
Figure 44. Americas CAR-T Cell Therapy Sales Market Share by Application (2021-2026)
Figure 45. United States CAR-T Cell Therapy Revenue Growth 2021-2026 ($ millions)
Figure 46. Canada CAR-T Cell Therapy Revenue Growth 2021-2026 ($ millions)
Figure 47. Mexico CAR-T Cell Therapy Revenue Growth 2021-2026 ($ millions)
Figure 48. Brazil CAR-T Cell Therapy Revenue Growth 2021-2026 ($ millions)
Figure 49. APAC CAR-T Cell Therapy Sales Market Share by Region in 2026
Figure 50. APAC CAR-T Cell Therapy Revenue Market Share by Region (2021-2026)
Figure 51. APAC CAR-T Cell Therapy Sales Market Share by Type (2021-2026)
Figure 52. APAC CAR-T Cell Therapy Sales Market Share by Application (2021-2026)
Figure 53. China CAR-T Cell Therapy Revenue Growth 2021-2026 ($ millions)
Figure 54. Japan CAR-T Cell Therapy Revenue Growth 2021-2026 ($ millions)
Figure 55. South Korea CAR-T Cell Therapy Revenue Growth 2021-2026 ($ millions)
Figure 56. Southeast Asia CAR-T Cell Therapy Revenue Growth 2021-2026 ($ millions)
Figure 57. India CAR-T Cell Therapy Revenue Growth 2021-2026 ($ millions)
Figure 58. Australia CAR-T Cell Therapy Revenue Growth 2021-2026 ($ millions)
Figure 59. China Taiwan CAR-T Cell Therapy Revenue Growth 2021-2026 ($ millions)
Figure 60. Europe CAR-T Cell Therapy Sales Market Share by Country in 2026
Figure 61. Europe CAR-T Cell Therapy Revenue Market Share by Country (2021-2026)
Figure 62. Europe CAR-T Cell Therapy Sales Market Share by Type (2021-2026)
Figure 63. Europe CAR-T Cell Therapy Sales Market Share by Application (2021-2026)
Figure 64. Germany CAR-T Cell Therapy Revenue Growth 2021-2026 ($ millions)
Figure 65. France CAR-T Cell Therapy Revenue Growth 2021-2026 ($ millions)
Figure 66. UK CAR-T Cell Therapy Revenue Growth 2021-2026 ($ millions)
Figure 67. Italy CAR-T Cell Therapy Revenue Growth 2021-2026 ($ millions)
Figure 68. Russia CAR-T Cell Therapy Revenue Growth 2021-2026 ($ millions)
Figure 69. Middle East & Africa CAR-T Cell Therapy Sales Market Share by Country (2021-2026)
Figure 70. Middle East & Africa CAR-T Cell Therapy Sales Market Share by Type (2021-2026)
Figure 71. Middle East & Africa CAR-T Cell Therapy Sales Market Share by Application (2021-2026)
Figure 72. Egypt CAR-T Cell Therapy Revenue Growth 2021-2026 ($ millions)
Figure 73. South Africa CAR-T Cell Therapy Revenue Growth 2021-2026 ($ millions)
Figure 74. Israel CAR-T Cell Therapy Revenue Growth 2021-2026 ($ millions)
Figure 75. Turkey CAR-T Cell Therapy Revenue Growth 2021-2026 ($ millions)
Figure 76. GCC Countries CAR-T Cell Therapy Revenue Growth 2021-2026 ($ millions)
Figure 77. Manufacturing Cost Structure Analysis of CAR-T Cell Therapy in 2026
Figure 78. Manufacturing Process Analysis of CAR-T Cell Therapy
Figure 79. Industry Chain Structure of CAR-T Cell Therapy
Figure 80. Channels of Distribution
Figure 81. Global CAR-T Cell Therapy Sales Market Forecast by Region (2027-2032)
Figure 82. Global CAR-T Cell Therapy Revenue Market Share Forecast by Region (2027-2032)
Figure 83. Global CAR-T Cell Therapy Sales Market Share Forecast by Type (2027-2032)
Figure 84. Global CAR-T Cell Therapy Revenue Market Share Forecast by Type (2027-2032)
Figure 85. Global CAR-T Cell Therapy Sales Market Share Forecast by Application (2027-2032)
Figure 86. Global CAR-T Cell Therapy Revenue Market Share Forecast by Application (2027-2032)
